Aligos Therapeutics Stock Forward View - Price Action Indicator
| ALGS Stock | USD 7.57 0.47 6.62% |
Momentum
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter -2.42 | EPS Estimate Current Year -5.96 | EPS Estimate Next Year -5.72 | Wall Street Target Price 80.25 | EPS Estimate Current Quarter -2.49 |
Hype-based context for Aligos Therapeutics connects recent headlines with price response and peer activity.
Aligos Therapeutics after-hype prediction price | $ 7.57 |
This sentiment layer is designed to be read with forecasting, technical, analyst, earnings, and momentum context.
Use Historical Fundamental Analysis of Aligos Therapeutics to cross-verify projections for Aligos Therapeutics. The historical series provides projection context.Aligos Therapeutics Additional Predictive Modules
Most predictive techniques to examine Aligos price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aligos using various technical indicators. When you analyze Aligos charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Aligos Therapeutics Volatility | Backtest Aligos Therapeutics | Information Ratio |
Aligos Therapeutics Trading Date Momentum
| On March 11 2026 Aligos Therapeutics was traded for 7.57 at the closing time. The top price for the day was 8.00 and the lowest listed price was 7.29 . The trading volume for the day was 48 K. The trading history from March 11, 2026 did not affect price variability. The overall trading delta against the current closing price is -3.70% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Aligos Therapeutics to competition |
Other Forecasting Options for Aligos Therapeutics
The price movement of Aligos is a central concern for all potential investors, regardless of their level of expertise. Aligos Stock price charts can be difficult to interpret due to the noise present in the data.Aligos Therapeutics Related Equities
The following equities are related to Aligos Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Aligos Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Aligos Therapeutics Market Strength Events
Market strength indicators applied to Aligos Therapeutics stock help investors assess the relative momentum and resilience of the security in different market environments. By using these indicators, traders can make more informed decisions about when to buy or sell Aligos Therapeutics.
Aligos Therapeutics Risk Indicators
Risk indicator analysis for Aligos Therapeutics is essential for accurately projecting its future price trajectory. By identifying the level of risk embedded in Aligos Therapeutics' investment, investors can make informed decisions about position sizing and risk mitigation.
| Mean Deviation | 4.27 | |||
| Standard Deviation | 5.46 | |||
| Variance | 29.86 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Aligos Therapeutics
Coverage intensity for Aligos Therapeutics matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Aligos Therapeutics Short Properties
Short sentiment tied to Aligos Therapeutics matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 9.9 M | |
| Cash And Short Term Investments | 77.8 M |
Additional Tools for Aligos Stock Analysis
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |